Basal cell carcinoma differential diagnosis: Difference between revisions
No edit summary |
No edit summary |
||
Line 18: | Line 18: | ||
|- | |- | ||
| '''Microcystic adnexal carcinoma'''||AKA sclerosing sweat duct carcinoma; simulate morpheaform variants of BCC; higher recurrence rate than BCC||Histopathology: there are more ductal structures lined by a cuticle of keratin, which are not prevalent in BCCs; it will occasionally be positive with cytokeratin 7 and CEA (usually negative in BCCs)<ref>{{cite journal| author=Smeets NW, Stavast-Kooy AJ, Krekels GA, Daemen MJ, Neumann HA| title=Adjuvant cytokeratin staining in Mohs micrographic surgery for basal cell carcinoma. | journal=Dermatol Surg | year= 2003 | volume= 29 | issue= 4 | pages= 375-7 | pmid=12656816 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12656816}}</ref> | | '''Microcystic adnexal carcinoma'''||AKA sclerosing sweat duct carcinoma; simulate morpheaform variants of BCC; higher recurrence rate than BCC||Histopathology: there are more ductal structures lined by a cuticle of keratin, which are not prevalent in BCCs; it will occasionally be positive with [[cytokeratin]] 7 and CEA (usually negative in BCCs)<ref>{{cite journal| author=Smeets NW, Stavast-Kooy AJ, Krekels GA, Daemen MJ, Neumann HA| title=Adjuvant cytokeratin staining in Mohs micrographic surgery for basal cell carcinoma. | journal=Dermatol Surg | year= 2003 | volume= 29 | issue= 4 | pages= 375-7 | pmid=12656816 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12656816}}</ref> | ||
|- | |- | ||
| '''Trichoepithelioma/trichoblastoma'''||There is a formation of papillary-mesenchymal bodies (follicular units that simulate bulb of the hair follicle); a characteristic stroma-stroma split; a lower apoptotic and mitotic rate than seen in BCC<ref>{{cite journal| author=Ackerman AB, Gottlieb GJ| title=Fibroepithelial tumor of pinkus is trichoblastic (Basal-cell) carcinoma. | journal=Am J Dermatopathol | year= 2005 | volume= 27 | issue= 2 | pages= 155-9 | pmid=15798443 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15798443}}</ref>||Histopathology: the characteristic stroma-epithelium split and increase in apoptotic bodies and mitotic figures is not seen; Immunohistochemical: a characteristic perinuclear dot-like pattern and high molecular weight cytokeratin cocktail | | '''Trichoepithelioma/trichoblastoma'''||There is a formation of papillary-mesenchymal bodies (follicular units that simulate bulb of the hair follicle); a characteristic stroma-stroma split; a lower [[apoptotic]] and mitotic rate than seen in BCC<ref>{{cite journal| author=Ackerman AB, Gottlieb GJ| title=Fibroepithelial tumor of pinkus is trichoblastic (Basal-cell) carcinoma. | journal=Am J Dermatopathol | year= 2005 | volume= 27 | issue= 2 | pages= 155-9 | pmid=15798443 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15798443}}</ref>||Histopathology: the characteristic stroma-epithelium split and increase in apoptotic bodies and mitotic figures is not seen; Immunohistochemical: a characteristic perinuclear dot-like pattern and high molecular weight cytokeratin cocktail | ||
|- | |- | ||
Line 30: | Line 30: | ||
|- | |- | ||
| '''Squamous cell carcinoma (SCC)'''||It may impossible to distinguish between BCC and SCC<ref>{{cite journal| author=Raasch BA, Buettner PG, Garbe C| title=Basal cell carcinoma: histological classification and body-site distribution. | journal=Br J Dermatol | year= 2006 | volume= 155 | issue= 2 | pages= 401-7 | pmid=16882181 | doi=10.1111/j.1365-2133.2006.07234.x | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16882181}}</ref>||Histopathology: larger cells with prominent nucleoli, foci of keratinization and formation of squamous whorls where the neoplastic cells tightly wrap around each other | | '''Squamous cell carcinoma (SCC)'''||It may impossible to distinguish between BCC and SCC<ref>{{cite journal| author=Raasch BA, Buettner PG, Garbe C| title=Basal cell carcinoma: histological classification and body-site distribution. | journal=Br J Dermatol | year= 2006 | volume= 155 | issue= 2 | pages= 401-7 | pmid=16882181 | doi=10.1111/j.1365-2133.2006.07234.x | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16882181}}</ref>||Histopathology: larger cells with prominent [[nucleoli]], foci of keratinization and formation of squamous whorls where the [[neoplastic]] cells tightly wrap around each other | ||
|} | |} |
Revision as of 19:26, 28 July 2015
Basal cell carcinoma Microchapters |
Diagnosis |
---|
Case Studies |
Basal cell carcinoma differential diagnosis On the Web |
American Roentgen Ray Society Images of Basal cell carcinoma differential diagnosis |
Risk calculators and risk factors for Basal cell carcinoma differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Saarah T. Alkhairy, M.D.
Overview
There are several differential diagnosis for basal cell carcinoma that may be differentiated clinically or histopathologically including microcystic adnexal carcinoma, trichoepithelioma/trichoblastoma, merkel cell carcinoma, and other squamous cell carcinoma.
Basal Carcinoma Differential Diagnosis
The following table summarizes common differential diagnosis for basal cell carcinoma[1]:
Disease or Condition | Differentiating Signs and Symptoms | Differentiating Tests |
Microcystic adnexal carcinoma | AKA sclerosing sweat duct carcinoma; simulate morpheaform variants of BCC; higher recurrence rate than BCC | Histopathology: there are more ductal structures lined by a cuticle of keratin, which are not prevalent in BCCs; it will occasionally be positive with cytokeratin 7 and CEA (usually negative in BCCs)[2] |
Trichoepithelioma/trichoblastoma | There is a formation of papillary-mesenchymal bodies (follicular units that simulate bulb of the hair follicle); a characteristic stroma-stroma split; a lower apoptotic and mitotic rate than seen in BCC[3] | Histopathology: the characteristic stroma-epithelium split and increase in apoptotic bodies and mitotic figures is not seen; Immunohistochemical: a characteristic perinuclear dot-like pattern and high molecular weight cytokeratin cocktail |
Merkel cell carcinoma | This is a highly malignant neoplasm derived from cutaneous neuroendocrine cells[4] | Histopathology: opaque nuclei, no nucleoli, and increased nuclear/cytoplasmic ratio, peripheral palisading might be present |
Squamous cell carcinoma (SCC) | It may impossible to distinguish between BCC and SCC[5] | Histopathology: larger cells with prominent nucleoli, foci of keratinization and formation of squamous whorls where the neoplastic cells tightly wrap around each other |
The following table summarizes other differential diagnosis for basal cell carcinoma:
Clinical Variant | Differential Diagnosis |
Nodular BCC | Intradermal nevus
Fibrous papule |
Superficial BCC | Discoid eczema
Actinic keratosis (solar keratosis) Lichen simplex |
Pigment BCC | Melanoma |
Sclerodermiform (morpheiform) BCC | Scar tissue
Localized scleroderma |
References
- ↑ https://online.epocrates.com/u/2935269/Basal+cell+carcinoma
- ↑ Smeets NW, Stavast-Kooy AJ, Krekels GA, Daemen MJ, Neumann HA (2003). "Adjuvant cytokeratin staining in Mohs micrographic surgery for basal cell carcinoma". Dermatol Surg. 29 (4): 375–7. PMID 12656816.
- ↑ Ackerman AB, Gottlieb GJ (2005). "Fibroepithelial tumor of pinkus is trichoblastic (Basal-cell) carcinoma". Am J Dermatopathol. 27 (2): 155–9. PMID 15798443.
- ↑ Massari LP, Kastelan M, Gruber F (2007). "Epidermal malignant tumors: pathogenesis, influence of UV light and apoptosis". Coll Antropol. 31 Suppl 1: 83–5. PMID 17469758.
- ↑ Raasch BA, Buettner PG, Garbe C (2006). "Basal cell carcinoma: histological classification and body-site distribution". Br J Dermatol. 155 (2): 401–7. doi:10.1111/j.1365-2133.2006.07234.x. PMID 16882181.